Local recurrence of malignant tumor of esophagus (disorder)
Clinical trial: Cytofloc
Year Started: 2018
Evaluation of a Non-Endoscopic Immunocytological Device (Cytosponge™) for post chemo-radiotherapy surveillance in patients with oesophageal cancer – a feasibility study
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| Followup records | 0 - 3 months |
| Pathology records | 0 - 3 months |
| Physiological/biochemical measurements | 0 - 3 months |
| Survey data | 0 - 3 months |
| Treatment records | 0 - 3 months |
Female
Young adult (18 - 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Tissue specimen | Biopsy (procedure) | RT | N/A | Not applicable | 0 - 10% |
| Plasma | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Adult (> 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Tissue specimen | Biopsy (procedure) | RT | N/A | Not applicable | 0 - 10% |
| Plasma | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Female
Adult (> 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Tissue specimen | Biopsy (procedure) | RT | N/A | Not applicable | 0 - 10% |
| Plasma | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young adult (18 - 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Tissue specimen | Biopsy (procedure) | RT | N/A | Not applicable | 0 - 10% |
| Plasma | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Malignant tumor of ovary (disorder)
Clinical Trial: 6MP
Year Started: 2011
See clinicaltrials.gov record NCT01432145 for more information about the study. Whole blood and plasma samples collected pre and post treatment in approx 70 participants and associated FFPE tumour tissue for approx 25 participants. Study data also available on request.
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- Completed
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Plasma | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Tissue specimen | Surgical procedure (procedure) | RT | N/A | Not applicable | 0 - 10% |
| Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Malignant tumor of ovary (disorder)
Clinical Trial: OCTOVA
Year Started: 2017
See ClinicalTrials.gov reference NCT03117933 for more information about the study. Whole blood and plasma samples pre and post-treatment with i.PARPi ii. control or iii. PARPi & anti-angiogenic. FFPE diagnostoc tumour sample.
- Access:
- Access restricted at present
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Plasma | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Tissue specimen | Surgical procedure (procedure) | RT | N/A | Affected | 0 - 10% |
| Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Malignant tumor of rectum (disorder)
Clinical Trial: CEDAR
Year Started: 2019
A Phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Female
Young adult (18 - 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Faeces | RT | Not applicable | 0 - 10% | ||
| RNA | -60°C to -85°C | Not applicable | 0 - 10% | ||
| Tissue specimen | RT | Paraffin | Not applicable | 0 - 10% | |
| Whole blood | RT | Not applicable | 0 - 10% |
Female
Adult (> 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Faeces | RT | Not applicable | 0 - 10% | ||
| RNA | -60°C to -85°C | Not applicable | 0 - 10% | ||
| Tissue specimen | RT | Paraffin | Not applicable | 0 - 10% | |
| Whole blood | RT | Not applicable | 0 - 10% |
Male
Young adult (18 - 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| RNA | -60°C to -85°C | Not applicable | 0 - 10% | ||
| Tissue specimen | RT | Not applicable | 0 - 10% | ||
| Whole blood | RT | Not applicable | 0 - 10% | ||
| Faeces | RT | Not applicable | 0 - 10% |
Male
Adult (> 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Faeces | RT | Not applicable | 0 - 10% | ||
| RNA | -60°C to -85°C | Not applicable | 0 - 10% | ||
| Tissue specimen | RT | Not applicable | 0 - 10% | ||
| Whole blood | RT | Not applicable | 0 - 10% |